Raised HDL cholesterol in Fabry disease: response to enzyme replacement therapy
- PMID: 15617195
- DOI: 10.1023/b:boli.0000045841.27968.06
Raised HDL cholesterol in Fabry disease: response to enzyme replacement therapy
Abstract
Fabry disease patients have increased risk of vascular disease despite cardioprotective increased HDL-cholesterol. Enzyme therapy does not significantly alter the lipid profile in the short term.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
